Express Scripts Trading Higher After Reaffirming 2015 Guidance, Initial Look At 2016

Shares of

gained more than 3 percent Tuesday morning and were trading at $89.73 after the company

and offered a brief look into its 2016 outlook. Express Scripts still expects to see its 2015 adjusted earnings per diluted share grow 13 to 14 percent over 2014's results. The company added that it expects to earn $6.08 to $6.28 in fiscal 2016 - representing a growth of 10 to 14 percent over the mid-point of its 2015 guidance range. Express Scripts also expects its full year 2016 EBITDA to be $7.23 billion to $7.43 billion, while its cash flow from operations will be between $4.6 billion and $5.1 billion. "The fundamentals of our business allow us to deliver solid financial results while making investments to continue our growth as a leading independent PBM and healthcare provider," said Tim Wentworth, Express Scripts' President in the company's press release. "We have an aligned book of business and a deep set of innovative solutions to help clients and patients. As we create value for our patients and clients, we create value for our shareholders."